缺少TBXAS1会导致对IL-6抑制剂有反应的自身炎症
Lin Liu1, Jun Wang2, Yan Ding3
1Urology & Nephrology Center, Department of Nephrology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, China; Department of Rheumatology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, and Liangzhu Laboratory of Zhejiang University, Hangzhou, China.
Annals of the rheumatic diseases
|October 29, 2025
概括
甲基氨酸合成酶1缺乏会导致Ghosal血细胞缺血症与自身炎症. 用托西利祖马布向介质素-6 (IL-6) 通过使炎症途径和代谢物水平正常化,有效地解决了症状.
科学领域:
- 遗传学和分子生物学
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
背景情况:
- 鼻腔血形形症 (GHDD) 与血素A合成酶1 (TBXAS1) 缺乏症有关.
- 两个患有TBXAS1缺乏症的患者出现了自身炎症,骨密度问题和贫血.
研究的目的:
- 为了阐明TBXAS1缺乏相关的自身炎症的分子机制.
- 研究针对GHDD的向治疗策略.
主要方法:
- 整体外体和桑格测序用于突变识别.
- 定量PCR,西式涂抹,质谱和细胞因子测试用于分析分子通路和代谢物水平.
- 细胞计时飞行时间和单细胞RNA测序以评估炎症反应和IL-6信号.
主要成果:
- 由于TBXAS1缺乏导致异常的eicosanoid积累,而增加的前列腺素E2则通过EP2/cAMP/CREB通路驱动IL-6的表达.
- 患者表现出全身炎症,特别是单细胞,并激活了IL-6信号传递.
- 用IL-6抑制剂托西利祖马布治疗导致症状完全消失,炎症标志物和骨密度正常化.
结论:
- 缺少TBXAS1将酸通路与全身性自身炎症联系在一起.
- 用tocilizumab准IL-6是一种有效的GHDD治疗方法.
- 这种方法可能有利于其他涉及阿拉基酸路径失调的疾病.
相关概念视频
T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
Autoimmune Disorders
1.4K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
1.4K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
478
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
478
The JAK-STAT Signaling Pathway
11.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.9K
TGF - β Signaling Pathway
10.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K


